← Leaderboards
Wenlong Bai
University Of South Florida
$2,481,550
Attributed
$2,481,550
Total exposure
3
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $464.4K · FY2005–09$500K$375K$250K$125K$0
'05
'06
'07
'08
'09
Funding mix
By agency
NIH$2,481,550 · 3
By mechanism
R01$2,069,065 · 2
R29$412,485 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of South Florida
Same institution · by research overlap
- Velda Janet Gonzalez-Mercado$1,108,050
- John Adams$29,453,928
Others in their field
Top investigators on “Cell Line”
- David Heimbrook · Leidos Biomedical Research, Inc.$236,973,333
- Dennis R. Burton · Scripps Research Institute$203,685,614
- Jay Arnold Tischfield · Rutgers, The State Univ Of N.J.$177,001,772
- John M Lachin · George Washington University$118,672,444
- David M Nathan · Massachusetts Institute Of Technology$118,672,444
- Fred M Gordin · Social And Scientific Systems, Inc.$82,802,056
Research focus
Cell LineProtein Protein InteractionReceptor BindingPhosphorylationGrowth FactorMitogen Activated Protein KinaseApoptosisTumor Suppressor ProteinsNeoplastic GrowthBiological Signal TransductionNeoplastic ProcessBreast NeoplasmsReporter GenesGel Mobility Shift AssayEstradiolEstrogen ReceptorsDrug ResistanceCyclinsOvary NeoplasmsCofactorFemale Reproductive System NeoplasmCyclin Dependent KinaseEnzyme Linked Immunosorbent AssayProtein Kinase
Grant awards (13)
Vitamin D and Ovarian Cancer Prevention and Treatment$244,382
R01 · FY2009 · CA · contact PI
Vitamin D and Ovarian Cancer Prevention and Treatment$244,382
R01 · FY2008 · CA · contact PI
Vitamin D and Ovarian Cancer Prevention and Treatment$244,382
R01 · FY2007 · CA · contact PI
Vitamin D and Ovarian Cancer Prevention and Treatment$251,681
R01 · FY2006 · CA · contact PI
Vitamin D and Ovarian Cancer Prevention and Treatment$257,738
R01 · FY2005 · CA
AR-PTEN Antagonism in Prostate Cell Growth And Apoptosis$206,625
R01 · FY2005 · CA
AR-PTEN Antagonism in Prostate Cell Growth And Apoptosis$206,625
R01 · FY2004 · CA
AR-PTEN Antagonism in Prostate Cell Growth And Apoptosis$206,625
R01 · FY2003 · CA
DIFFERENTIAL ACTIVATION OF HER BY MEKK1 IN TUMOR CELLS$107,759
R29 · FY2003 · CA
AR-PTEN Antagonism in Prostate Cell Growth And Apoptosis$206,625
R01 · FY2002 · CA
DIFFERENTIAL ACTIVATION OF HER BY MEKK1 IN TUMOR CELLS$104,592
R29 · FY2002 · CA
DIFFERENTIAL ACTIVATION OF HER BY MEKK1 IN TUMOR CELLS$101,546
R29 · FY2001 · CA
DIFFERENTIAL ACTIVATION OF HER BY MEKK1 IN TUMOR CELLS$98,588
R29 · FY2000 · CA